Results 181 to 190 of about 20,692 (311)

Erectile dysfunction in dermatology and venereology: From aetiopathogenic mechanisms to practical considerations for dermato‐venereologists

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Multiple inflammatory, infectious and autoimmune dermato‐venereological conditions are associated with erectile dysfunction (ED) due to underlying intricate vasculogenic, neurogenic, endocrine and psychogenic mechanisms. It is recommended that practitioners screen dermatology patients for ED and associated comorbidities, provide personalized lifestyle ...
Andrei Tanasov, George‐Sorin Tiplica
wiley   +1 more source

Dupilumab in the Treatment of Moderate to Severe Asthma: An Evidence-Based Review

, 2019
Kiran Kumar Rathinam, Justin Jacob Abraham, Thangavel Mahalingam Vijayakumar   +2 more
openalex   +1 more source

Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: Results of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry [PDF]

, 2020
Angela L. Bosma, Linde E. M. de Wijs, Michel H. Hof, Beau R. van Nieuwenhuizen, Louise A. A. Gerbens, Maritza A. Middelkamp‐Hup, DirkJan Hijnen, Phyllis I. Spuls   +7 more
openalex   +1 more source

Dupilumab-induced pityriasis rosea

JAAD Case Reports, 2023
Morgan Zabel, BS, Grace A. Hile, MD, Alanna Shefler, MD, Paul W. Harms, MD, May P. Chan, MD, Jennifer B. Mancuso, MD   +5 more
openaire   +3 more sources

Treatment of juvenile bullous pemphigoid with lebrikizumab

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Marcel Wittenberg, Farzan Solimani, Amrei Dilling, Rawan Snobar, Kamran Ghoreschi, Marisa Klemp, Kerstin Kusch   +6 more
wiley   +1 more source

European Guideline (EuroGuiDerm) on atopic eczema: Living update

Journal of the European Academy of Dermatology and Venereology, EarlyView.
The updated guideline includes a new evidence‐based recommendation for the IL‐13 inhibitor lebrikizumab. In addition, the Janus kinase inhibitors baricitinib and abrocitinib, which were initially only approved for adult patients, are now also recommended for children from the age of 2 and adolescents from the age of 12, respectively.
A. Wollenberg, M. Kinberger, B. Arents, N. Aszodi, S. Barbarot, T. Bieber, H. A. Brough, P. Calzavara‐Pinton, S. Christen‐Zaech, M. Deleuran, M. Dittmann, N. Fosse, K. Gáspár, L. A. A. Gerbens, U. Gieler, G. Girolomoni, S. Gregoriou, S. Holland, C. G. Mortz, A. Nast, U. Nygaard, E. M. Rehbinder, J. Ring, M. Rossi, E. Serra‐Baldrich, D. Simon, Z. Z. Szalai, J. C. Szepietowski, A. Torrelo, T. Werfel, R. N. Werner, C. Flohr   +31 more
wiley   +1 more source

Dupilumab as Immunomodulatory Rescue for Severe Recalcitrant Pemphigus Vulgaris: A Case Report and Literature Review. [PDF]

Clin Cosmet Investig Dermatol
Boonpethkaew S, Chanprapaph K.
europepmc   +1 more source

Eye Complications During Dupilumab Treatment for Severe Atopic Dermatitis

, 2019
Lina U. Ivert, Carl‐Fredrik Wahlgren, Lina U. Ivert, Maria Lundqvist, Maria Bradley   +4 more
openalex   +2 more sources

Risk of Cardiovascular Disease and Cancer in Patients Initiating JAK Versus IL‐4/‐13 Inhibitors for Atopic Dermatitis

International Journal of Dermatology, EarlyView.
Sizheng Steven Zhao, Gema Hernandez, Uazman Alam   +2 more
wiley   +1 more source

Dupilumab shows no elevated risk for maternal adverse pregnancy outcomes: A propensity‐matched cohort study

Journal of the European Academy of Dermatology and Venereology, EarlyView.
This large‐scale, propensity‐matched retrospective cohort study provides evidence that dupilumab treatment during pregnancy is not associated with an elevated risk of maternal adverse pregnancy outcomes (APOs). By utilizing real‐world data, it contributes critical insights into dupilumab's safety profile in pregnant women, addressing a crucial gap in ...
Sophie L. Preuß, Katja Bieber, Artem Vorobyev, Andreas Recke, Eva Lotta Moderegger, Henner Zirpel, Evelyn Gaffal, Diamant Thaçi, Khalaf Kridin, Ralf J. Ludwig   +9 more
wiley   +1 more source